Ergomed plc Notice of AGM and Annual Report (6079Y)
14 Mayo 2021 - 1:00AM
UK Regulatory
TIDMERGO
RNS Number : 6079Y
Ergomed plc
14 May 2021
PRESS RELEASE
Notice of AGM and Annual Report
Guildford, UK - 14 May 2021 : Ergomed plc (LSE: ERGO) ("Ergomed"
or the "Company"), a company focused on providing specialised
services to the pharmaceutical industry, announces that its Annual
General Meeting ("AGM") will be held at 80 Coleman Street, London,
EC2R 6PA at 9:30 a.m. on Thursday, 10 June 2021. In light of the UK
government's current COVID-19 measures, it is expected that the AGM
will be run as a closed meeting and shareholders will not be able
to attend in person.
Ergomed's Annual Report and Accounts for the year ended 31
December 2020, Notice of AGM and Form of Proxy will be available on
the Company's website at www.ergomedplc.com and are being mailed to
its shareholders today.
ENDS
Enquiries:
Ergomed plc Tel: +44 (0) 1483 402
975
Miroslav Reljanović (Executive
Chairman)
Richard Barfield (Chief Financial Officer)
Numis Securities Limited Tel: +44 (0) 20 7260
1000
Freddie Barnfield / Matthew O'Dowd
(Nominated Adviser)
James Black (Broker)
Consilium Strategic Communications Tel: +44 (0) 20 3709
5700
Chris Gardner / Matthew Neal ergomed@consilium-comms.com
Angela Gray
About Ergomed plc
Ergomed provides specialist services to the pharmaceutical
industry spanning all phases of clinical development, post-approval
pharmacovigilance and medical information. Ergomed's fast-growing
services business includes an industry-leading suite of specialist
pharmacovigilance (PV) solutions, integrated under the
PrimeVigilance brand and a full range of high-quality clinical
research and trial management services under the Ergomed brand
(CRO). For further information, visit: http://ergomedplc.com .
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NOADKNBKDBKBKPD
(END) Dow Jones Newswires
May 14, 2021 02:00 ET (06:00 GMT)
Ergomed (LSE:ERGO)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Ergomed (LSE:ERGO)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024